North America Diabetes Care Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Glucose Monitoring Devices and Insulin Delivery Devices) and End User (Homecare and Hospitals & Clinics)
The North America diabetes care devices market is expected to grow from US$ 11,149.93 million in 2022 to US$ 16,386.63 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.
Diabetes among the geriatric population is a growing public health burden. It is a major cause of morbidity and mortality in the aging population and leads to various chronic complications. Moreover, this population is growing exponentially. As per a UN report (2019), in 2019, there were 200.4 million people aged 65 and older in North America. Moreover, according to a report by the UN (2019), the regional geriatric population is expected to double over the next three decades. The geriatric population is more likely to have diabetes than the younger population, and its effect on the quality of life is particularly more in the former population. With a rise in the geriatric population, the prevalence of diabetes has increased. Therefore, there is an increase in demand for diabetes care devices, which is driving the market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America diabetes care devices market. The North America diabetes care devices market is expected to grow at a good CAGR during the forecast period.
North America Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million)
North America Diabetes Care Devices Market Segmentation
The North America diabetes care devices market is segmented based on type, end user, and country. Based on type, the North America diabetes care devices market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further categorized into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. In terms of end user, the North America diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the North America diabetes care devices market has been categorized into the US, Canada, and Mexico. The US would dominate the market in 2022.
B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the North America diabetes care devices market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Diabetes Care Devices Market – By Type
1.3.2 North America Diabetes Care Devices Market – By End User
1.3.3 North America Diabetes Care Devices Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Diabetes Care Devices Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Diabetes Care Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Escalating Incidence of Diabetes
5.1.2 Surging Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Diabetes Care Devices
5.3 Market Opportunities
5.3.1 Growing Medical Tourism in Developing Countries
5.4 Future Trends
5.4.1 Rapid Technological Advancements in Diabetes Care Devices
5.5 Impact Analysis
6. Diabetes Care Devices Market– North America Analysis
6.1 North America Diabetes Care Devices Market Revenue Forecast and Analysis
7. North America Diabetes Care Devices Market Analysis – By Type
7.1 Overview
7.2 North America Diabetes Care Devices Market Revenue and Forecasts Analysis, By Type (US$ Mn)
7.3 Glucose Monitoring Devices Market
7.3.1 Overview
7.3.2 Glucose Monitoring Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Glucometers Market
7.3.3.1 Overview
7.3.3.2 Glucometers Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Lancets Market
7.3.4.1 Overview
7.3.4.2 Lancets Market Revenue and Forecast to 2028 (US$ Mn)
7.3.5 Testing Strips Market
7.3.5.1 Overview
7.3.5.2 Testing Strips Market Revenue and Forecast to 2028 (US$ Mn)
7.3.6 Other Glucose Monitoring Devices Market
7.3.6.1 Overview
7.3.6.2 Other Glucose Monitoring Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Insulin Delivery Devices Market
7.4.1 Overview
7.4.2 Insulin Delivery Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.4.3 Insulin Pens Market
7.4.3.1 Overview
7.4.3.2 Insulin Pens Market Revenue and Forecast to 2028 (US$ Mn)
7.4.4 Insulin Syringes Market
7.4.4.1 Overview
7.4.4.2 Insulin Syringes Market Revenue and Forecast to 2028 (US$ Mn)
7.4.5 Insulin Pumps Market
7.4.5.1 Overview
7.4.5.2 Insulin Pumps Market Revenue and Forecast to 2028 (US$ Mn)
7.4.6 Other Insulin Delivery Devices Market
7.4.6.1 Overview
7.4.6.2 Other Insulin Delivery Devices Market Revenue and Forecast to 2028 (US$ Mn)
8. North America Diabetes Care Devices Market Analysis– By End User
8.1 Overview
8.2 North America Diabetes Care Devices Market Revenue and Forecasts Analysis, By End User (US$ Mn)
8.3 Hospitals & Clinics Market
8.3.1 Overview
8.3.2 Hospitals & Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 Homecare Market
8.4.1 Overview
8.4.2 Homecare Market Revenue and Forecasts to 2028 (US$ Mn)
9. North America Diabetes Care Devices Market – Country Analysis
9.1 North America: Diabetes Care Devices Market
9.1.1 Overview
9.1.2 North America: Diabetes Care Devices Market, by Country, 2022 & 2028 (%)
9.1.2.1 US: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.1 Overview
9.1.2.1.2 US: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.3 US: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)
9.1.2.1.3.1 US: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)
9.1.2.1.3.2 US: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)
9.1.2.1.4 US: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)
9.1.2.2 Canada: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 Overview
9.1.2.2.2 Canada: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.3 Canada: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)
9.1.2.2.3.1 Canada: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)
9.1.2.2.3.2 Canada: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)
9.1.2.2.4 Canada: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)
9.1.2.3 Mexico: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 Overview
9.1.2.3.2 Mexico: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.3 Mexico: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)
9.1.2.3.3.1 Mexico: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)
9.1.2.3.3.2 Mexico: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)
9.1.2.3.4 Mexico: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)
10. Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 BD
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novo Nordisk A/S
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 B. Braun Melsungen AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Medtronic
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Tandem Diabetes Care Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Insulet Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Eli Lilly and Company.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Dexcom, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Terumo Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Diabetes Care Devices Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. US: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)
Table 3. US: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)
Table 4. US: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)
Table 5. US: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)
Table 6. Canada: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)
Table 7. Canada: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)
Table 8. Canada: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)
Table 9. Canada: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)
Table 10. Mexico: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)
Table 11. Mexico: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)
Table 12. Mexico: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)
Table 13. Mexico: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)
Table 14. Organic Developments Done By Companies
Table 15. Inorganic Developments Done By Companies
Table 16. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Diabetes Care Devices Market Segmentation
Figure 2. North America Diabetes Care Devices Market Segmentation, By Country
Figure 3. North America Diabetes Care Devices Market Overview
Figure 4. North America Diabetes Care Devices Market, By Type
Figure 5. North America Diabetes Care Devices Market, By Country
Figure 7. North America: PEST Analysis
Figure 8. Experts’ Opinion
Figure 9. North America Diabetes Care Devices Market: Impact Analysis of Drivers and Restraints
Figure 10. North America Diabetes Care Devices Market– Revenue Forecast and Analysis
Figure 11. North America Diabetes Care Devices Market Revenue and Forecast Analysis, By Type 2022 and 2028 (%)
Figure 12. North America Glucose Monitoring Devices Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Glucometers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Lancets Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Testing Strips Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. North America Other Glucose Monitoring Devices Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. North America Insulin Delivery Devices Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Insulin Pens Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Insulin Syringes Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Insulin Pumps Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Others Insulin Delivery Devices Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. North America Diabetes Care Devices Market Revenue and Forecast Analysis, by End User 2022 & 2028 (%)
Figure 23. North America Hospitals & Clinics Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Homecare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. North America: Diabetes Care Devices Market, by Key Country – Revenue (2022) (USD Million)
Figure 26. North America: Diabetes Care Devices Market, by Country, 2022 & 2028 (%)
Figure 27. US: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Canada: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Mexico: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)
- B. Braun Melsungen AG
- BD
- Dexcom, Inc.
- Eli Lilly and Company.
- F. Hoffmann-La Roche Ltd.
- Insulet Corporation
- Medtronic
- Novo Nordisk A/S
- Tandem Diabetes Care Inc.
- Terumo Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America diabetes care devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America diabetes care devices market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the diabetes care devices market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution